Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Cullinan Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 135
- +23 vs. Q1 2024
- Shares held
- 62.9M
- +23.6M (+60.0%) vs. Q1 2024
- Total value
- $1.10B
- +$427.3M (+63.8%) vs. Q1 2024
- New holders
- 39
- 60 more added
- Sold out
- 16
- 26 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MPM Oncology Impact Management LP | 7,648,268 | $133.4M | 20.73% | 00.0% | Unchanged |
| BVF Inc | 5,750,683 | $100.3M | 2.81% | +2,553,982+79.9% | Added |
| BlackRock Inc. | 3,550,207 | $61.9M | 0.00% | +1,121,214+46.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 3,280,237 | $57.2M | 0.95% | +2,141,706+188.1% | Added |
| Vanguard Group Inc | 2,871,375 | $50.1M | 0.00% | +1,097,030+61.8% | Added |
| Franklin Resources Inc | 2,444,130 | $42.6M | 0.01% | −252,632−9.4% | Reduced |
| Adage Capital Partners GP, L.L.C. | 2,232,829 | $38.9M | 0.07% | +1,282,829+135.0% | Added |
| Blue Owl Capital Holdings LP | 2,049,172 | $35.7M | 9.94% | −875,670−29.9% | Reduced |
| Citadel Advisors LLC | 1,943,139 | $33.9M | 0.03% | +833,968+75.2% | Added |
| State Street Corp | 1,941,188 | $33.9M | 0.00% | +515,729+36.2% | Added |
| Alliancebernstein L.P. | 1,728,545 | $30.1M | 0.01% | +1,695,345+5,106.5% | Added |
| Avidity Partners Management LP | 1,559,826 | $27.2M | 1.16% | +1,559,826 | New |
| Paradigm Biocapital Advisors LP | 1,542,805 | $26.9M | 1.03% | +194,790+14.5% | Added |
| VR Adviser, LLC | 1,379,965 | $24.1M | 1.53% | +1,379,965 | New |
| Holocene Advisors, LP | 1,316,005 | $23.0M | 0.10% | +1,316,005 | New |
| Nextech Invest AG | 1,221,145 | $21.3M | 3.58% | 00.0% | Unchanged |
| Marshall Wace, LLP | 1,184,037 | $20.6M | 0.03% | +1,136,993+2,416.9% | Added |
| OrbiMed Advisors LLC | 1,147,655 | $20.0M | 0.43% | +630,049+121.7% | Added |
| Cormorant Asset Management, LP | 1,125,000 | $19.6M | 1.14% | +1,125,000 | New |
| Artal Group S.A. | 1,057,949 | $18.5M | 0.47% | +1,057,949 | New |
| RTW Investments, LP | 1,052,630 | $18.4M | 0.28% | +1,052,630 | New |
| Geode Capital Management, LLC | 976,486 | $17.0M | 0.00% | +299,156+44.2% | Added |
| Tang Capital Management LLC | 921,138 | $16.1M | 1.64% | +350,000+61.3% | Added |
| Morgan Stanley | 838,283 | $14.6M | 0.00% | −314,361−27.3% | Reduced |
| Dimensional Fund Advisors LP | 759,760 | $13.2M | 0.00% | −233,617−23.5% | Reduced |
| Perceptive Advisors LLC | 749,916 | $13.1M | 0.32% | +749,916 | New |
| Rock Springs Capital Management LP | 658,338 | $11.5M | 0.35% | +658,338 | New |
| Foresite Capital Management V, LLC | 657,905 | $11.5M | 7.33% | +657,905 | New |
| Boxer Capital, LLC | 657,895 | $11.5M | 0.60% | +657,895 | New |
| Twin Focus Capital Partners, LLC | 595,489 | $10.4M | 1.66% | +595,489 | New |
| Deutsche Bank AG | 555,067 | $9.68M | 0.00% | +5,791+1.1% | Added |
| Goldman Sachs Group Inc | 452,787 | $7.90M | 0.00% | +283,420+167.3% | Added |
| Renaissance Technologies LLC | 421,708 | $7.35M | 0.01% | +100,608+31.3% | Added |
| Bank of America Corp | 412,745 | $7.20M | 0.00% | +281,396+214.2% | Added |
| Ameriprise Financial Inc | 403,878 | $7.04M | 0.00% | −16,339−3.9% | Reduced |
| Lynx1 Capital Management LP | 377,323 | $6.58M | 2.37% | +377,323 | New |
| Charles Schwab Investment Management Inc | 370,631 | $6.46M | 0.00% | +112,758+43.7% | Added |
| CenterBook Partners LP | 341,262 | $5.95M | 0.37% | +341,262 | New |
| Northern Trust Corp | 296,852 | $5.18M | 0.00% | +32,903+12.5% | Added |
| PFM Health Sciences, LP | 296,036 | $5.16M | 0.28% | +40,069+15.7% | Added |
| Affinity Asset Advisors, LLC | 263,817 | $4.60M | 0.72% | +5,229+2.0% | Added |
| Nuveen Asset Management, LLC | 217,766 | $3.80M | 0.00% | +124,544+133.6% | Added |
| D. E. Shaw & Co., Inc. | 212,448 | $3.71M | 0.01% | +150,827+244.8% | Added |
| Barclays PLC | 197,314 | $3.44M | 0.00% | +157,122+390.9% | Added |
| Qube Research & Technologies Ltd | 190,520 | $3.32M | 0.01% | +75,408+65.5% | Added |
| Braidwell LP | 176,173 | $3.07M | 0.10% | −1,064,692−85.8% | Reduced |
| Voloridge Investment Management, LLC | 163,047 | $2.84M | 0.01% | +163,047 | New |
| UBS Group AG | 159,980 | $2.79M | 0.00% | −6,760−4.1% | Reduced |
| Balyasny Asset Management LLC | 150,708 | $2.63M | 0.01% | +150,708 | New |
| Ensign Peak Advisors, Inc | 148,773 | $2.59M | 0.00% | +148,773 | New |
| Bank of New York Mellon Corp | 137,997 | $2.41M | 0.00% | +43,757+46.4% | Added |
| First Trust Advisors LP | 136,887 | $2.39M | 0.00% | +41,116+42.9% | Added |
| Assenagon Asset Management S.A. | 114,195 | $1.99M | 0.00% | +114,195 | New |
| Rafferty Asset Management, LLC | 104,651 | $1.83M | 0.01% | +7,596+7.8% | Added |
| Jacobs Levy Equity Management, Inc | 98,296 | $1.71M | 0.01% | +98,296 | New |
| Jane Street Group, LLC | 96,596 | $1.68M | 0.00% | +75,592+359.9% | Added |
| Walleye Capital LLC | 92,869 | $1.62M | 0.02% | +92,869 | New |
| SG Americas Securities, LLC | 85,172 | $1.49M | 0.01% | +75,236+757.2% | Added |
| American Century Companies Inc | 76,018 | $1.33M | 0.00% | +18,840+32.9% | Added |
| E Fund Management Co., Ltd. | 74,827 | $1.30M | 0.07% | +74,827 | New |
| Swiss National Bank | 73,600 | $1.28M | 0.00% | +27,300+59.0% | Added |
| Wellington Management Group LLP | 72,098 | $1.26M | 0.00% | +3,740+5.5% | Added |
| UBS Asset Management Americas Inc | 68,534 | $1.20M | 0.00% | +68,534 | New |
| UBS Oconnor LLC | 61,975 | $1.08M | 0.03% | +2,623+4.4% | Added |
| Two Sigma Investments, LP | 57,361 | $1.00M | 0.00% | +57,361 | New |
| Rhumbline Advisers | 54,351 | $947.9K | 0.00% | +7,649+16.4% | Added |
| ADAR1 Capital Management, LLC | 53,261 | $928.9K | 0.19% | +53,261 | New |
| Invesco Ltd. | 49,361 | $860.9K | 0.00% | +1,954+4.1% | Added |
| Algert Global LLC | 39,884 | $695.6K | 0.02% | −39,796−49.9% | Reduced |
| Legal & General Group Plc | 39,251 | $684.5K | 0.00% | +19,690+100.7% | Added |
| Jump Financial, LLC | 37,462 | $653.3K | 0.01% | +15,772+72.7% | Added |
| California State Teachers Retirement System | 36,656 | $639.3K | 0.00% | +12,904+54.3% | Added |
| Russell Investments Group, Ltd. | 34,293 | $598.1K | 0.00% | +34,293 | New |
| STRS Ohio | 34,100 | $594.7K | 0.00% | +2,200+6.9% | Added |
| Sherbrooke Park Advisers LLC | 25,976 | $453.0K | 0.08% | +25,976 | New |
| NEOS Investment Management LLC | 24,023 | $419.0K | 0.02% | +7,635+46.6% | Added |
| JPMorgan Chase & Co | 23,268 | $405.8K | 0.00% | +3,798+19.5% | Added |
| MetLife Investment Management | 22,726 | $396.3K | 0.00% | +9,389+70.4% | Added |
| Citigroup Inc | 22,107 | $385.5K | 0.00% | −63,467−74.2% | Reduced |
| Price T Rowe Associates Inc | 20,799 | $363.0K | 0.00% | −2,043−8.9% | Reduced |
| Two Sigma Advisers, LP | 20,800 | $362.8K | 0.00% | +1,200+6.1% | Added |
| Corebridge Financial, Inc. | 20,796 | $362.7K | 0.00% | +20,796 | New |
| Birchview Capital, LP | 20,000 | $348.8K | 0.32% | −5,114−20.4% | Reduced |
| Profund Advisors LLC | 19,352 | $337.5K | 0.01% | +4,089+26.8% | Added |
| Janus Henderson Group PLC | 18,528 | $322.7K | 0.00% | +18,528 | New |
| Y-Intercept (Hong Kong) Ltd | 18,026 | $314.4K | 0.02% | +18,026 | New |
| Harbor Capital Advisors, Inc. | 17,481 | $305.0K | 0.02% | +4,941+39.4% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 16,956 | $294.3K | 0.00% | +16,956 | New |
| Mariner, LLC | 16,354 | $285.2K | 0.00% | +16,354 | New |
| State of Wisconsin Investment Board | 16,247 | $283.3K | 0.00% | −3,848−19.1% | Reduced |
| New York State Common Retirement Fund | 15,818 | $275.9K | 0.00% | +6,308+66.3% | Added |
| Susquehanna International Group, LLP | 15,486 | $270.1K | 0.00% | −19,129−55.3% | Reduced |
| Manufacturers Life Insurance Company, The | 15,175 | $264.7K | 0.00% | +4,393+40.7% | Added |
| Commonwealth Equity Services, LLC | 14,604 | $255.0K | 0.00% | −100−0.7% | Reduced |
| Martingale Asset Management L P | 14,022 | $244.5K | 0.01% | −28,507−67.0% | Reduced |
| Wells Fargo & Company | 13,892 | $242.3K | 0.00% | +4,692+51.0% | Added |
| Nebula Research & Development LLC | 13,125 | $228.9K | 0.04% | −11,528−46.8% | Reduced |
| Voya Investment Management LLC | 12,969 | $226.2K | 0.00% | +12,969 | New |
| Exchange Traded Concepts, LLC | 12,852 | $224.1K | 0.01% | −3,998−23.7% | Reduced |
| Alpine Global Management, LLC | 12,164 | $212.1K | 0.04% | +12,164 | New |